Skip to main content

3-Hour Virtual Seminar on Analytical Method Validation Process

Compliance Key INC - Online HIPAA Training for Employees

                                                 Angela Bazigos
Angela Bazigos, is the CEO of Touchstone Technologies, Inc. She has 40 years of experience working in hospitals and Pharma industry. Her background includes companies like Roche, Novartis, Genentech and PriceWaterhouseCoopers in GLP, GCP, GMP, Medical Device and Data Integrity Roles. She has held positions such as Chief Compliance Officer, QA Director and has acted on behalf CEO for communications with FDA. 
 Webinar Id: LSHCAB004
 10:00 AM PT | 01:00 PM ET
 11/02/2017
  Duration 180 mins 
Overview
Use of analytical methods is widespread. However, there are no formally accepted guideline or formats for the overall process of design, development, optimization & validation of analytical methods
Many analytical methods, lacking full and adequate validation have been introduced into the open literature and allowed to assume aura of authenticity but, they may never work or be used with samples that are typically encountered
This webinar will explain the validation of analytical procedures for determining the suitability of a given methodology for providing useful analytical data.
Why should you attend this webinar?
Method validation is the process of demonstrating that analytical procedures are suitable for their intended use and that they support the identity, strength, quality, purity, and potency of the drug substances and drug or other products.
In this webinar, you will learn:
  • Process to validate method
  • Components of method validation
  • Regulations USP / ICH / FDA
  • How we know what FDA is looking for
  • How to use Quality by Design (QbD) to enhance Analytical Method Validation
Areas Covered in the Session:
  • Method Development, Optimization and Validation Approaches
  • Method Validation - High Level
  • System Suitability
  • Validation Components
    • Accuracy
    • Precision
    • Repeatability
    • Interm. Prec.
    • Specificity
    • LOD LOQ
    • Linearity
    • Range
  • LifeCycle Concept
  • Validation Planning
  • Method Validation Protocol
  • Method Transfer & Revalidation
  • European and International regulatory bodies and their guidelines on different aspects of Method Validation QA
  • Quality by Design 
    • Lifecycle management of analytical procedures: development, validation, and routine use
    • Using principles of Quality by Design to get most robust methods
    • Defining validation parameters, acceptance criteria, and test procedures 
    • Templates and examples for efficient and consistent documentations
  • How we know what FDA is looking for
    • FDA Systems Based Inspection: Laboratory System
    • FDA 483s
    • FDA Warning Letters
Who can Benefit:
  • Any companies that have a laboratory or manufacturing operation
  • E.g. Merck
  • Pfizer
  • Food Companies
  • Academia
  • Agricultural
  • Tobacco
  • Veterinary
  • CLIA laboratories
  • CAP accredited laboratories
  • Genomic testing laboratories
  • Etc.

Comments

Popular posts from this blog

New 2019 HIPAA Guidance on De-Identifying Protected Health Information

Compliance Key  -   HIPAA Compliance Training Overview This seminar will be addressing how practice/business managers or compliance officers need to get their HIPAA house in order, as HIPAA is now fully enforced and the government is not using kid gloves anymore. It will also address major 2019 changes taking place with the Health and Human Services regarding the enforcement of the HIPAA law as well as detailed discussions on the Phase 2 audit process and current events regarding HIPAA cases (both in courtrooms and from real-life Audits). Our instructor - Mr. Brian Tuttle  has over 20 years of experience in working as Compliance auditor and has been an expert witness on multiple HIPAA cases. He`ll thoroughly explain on HOW and in WHAT scenarios patients can claim for cash remedies. More importantly, Brian will show you how to limit those risks by simply taking proactive steps and utilizing best practices. Why should you attend this seminar? This Sem...

Classifying Medical Devices in US and EU

Compliance Key INC  -  Healthcare Compliance Webinars Overview The Food and Drug Administration (FDA) has established classifications for approximately 1,700 different generic types of devices and grouped them into 16 medical specialties referred to as panels. Each of these generic types of devices is assigned to one of three regulatory classes based on the level of control necessary to assure the safety and effectiveness of the device.The determination process, how you apply the classification process to your device, is complex and requires several levels of analysis to make the proper device classification. Proper medical device classification is the fundamental first step in submitting your device for approval anywhere in the world. This webinar will detail the medical device classification process for the United States through the FDA and will overview the very complex process for medical device classification within the EU. Specifically, this webinar will provid...

HIPAA Compliant Fundraising Under New Rules - 2019

Compliance Key  -  H ipaa   Compliance Training HIPAA Compliant Fundraising Under New Rules - 2019 Joel Simon Joel Simon is one of the nation's leading experts on the fund raising aspects of HIPAA. Joel has been a member of the Maryland bar for 30 years, and his professional experience includes work as the assistant general counsel of a community hospital. Joel is an editor of "Fundraising Under HIPAA" published by the Association of Fundraising Professionals. He has lectured on Fund Raising under HIPAA to national audiences since the original HIPAA regulations were first proposed 17 years ago. Read More Overview Not-for-Profit organizations that are governed by HIPAA often need or want to fund raise from their patients, clients, or families. What protocols should be in place to maximize philanthropic opportunities under HIPAA? What compliance measures need to be in place and assessed to properly use protected health information for fund raisi...